🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a two stage study, with an initial dose escalation phase I study an...
Status
Active Not Recruiting
Location
Velindre NHS Trust
Start Date
2014-05-07
Trial ID
NCT01992952
Treatments Being Tested
This study will assess the efficacy and safety of capivasertib plus abirate...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-07-13
Trial ID
NCT04493853
Treatments Being Tested
In the last decade, the prevalence of malaria has been escalating at an ala...
Status
Completed
Location
Central Primary Health Centre, Ukpenu, Road, Ekpoma.
Start Date
2010-08
Trial ID
NCT01152931
Treatments Being Tested
This Phase I clinical study is designed to evaluate the safety and determin...
Status
Completed
Location
Hanoi Medical University
Start Date
2025-02-13
Trial ID
NCT07300202
The AGILE platform master protocol allows incorporation of a range of ident...
Status
Recruiting
Location
Desmond Tutu Health Foundation
Start Date
2020-07-03
Trial ID
NCT04746183
Anxiety about needles is a concern commonly expressed by diabetics when beg...
Status
Completed
Location
AMCR Institute, Inc.
Start Date
2010-10
Trial ID
NCT01231984
Treatments Being Tested
The current national acute lymphoblastic leukaemia (ALL) trial in adults in...
Status
Active Not Recruiting
Location
Heart of England Nhs Foundation Trust
Start Date
2018-11-22
Trial ID
NCT03821610
Treatments Being Tested
This is a multi-centre, long term, double blind, clinical protocol for Nana...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11
Trial ID
NCT04808531
Treatments Being Tested
To determine whether the combination of gemcitabine/carboplatin with hydrox...
Status
Terminated
Location
Dorset County Hospital NHS Foundation Trust
Start Date
2017-03-14
Trial ID
NCT02722369
Treatments Being Tested
TALEN is a prospective randomised double-blind placebo-controlled phase 2 s...
Status
Completed
Location
John Radcliffe Hospital
Start Date
2021-02-01
Trial ID
NCT07027670
Treatments Being Tested